Cargando…
Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062523/ https://www.ncbi.nlm.nih.gov/pubmed/37006492 http://dx.doi.org/10.3389/fneur.2023.1146027 |
| _version_ | 1785017511320748032 |
|---|---|
| author | Berger, Joseph R. Hartung, Hans-Peter |
| author_facet | Berger, Joseph R. Hartung, Hans-Peter |
| author_sort | Berger, Joseph R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10062523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100625232023-03-31 Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies Berger, Joseph R. Hartung, Hans-Peter Front Neurol Neurology Frontiers Media S.A. 2023-03-16 /pmc/articles/PMC10062523/ /pubmed/37006492 http://dx.doi.org/10.3389/fneur.2023.1146027 Text en Copyright © 2023 Berger and Hartung. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neurology Berger, Joseph R. Hartung, Hans-Peter Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title | Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title_full | Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title_fullStr | Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title_full_unstemmed | Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title_short | Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| title_sort | commentary: progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies |
| topic | Neurology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062523/ https://www.ncbi.nlm.nih.gov/pubmed/37006492 http://dx.doi.org/10.3389/fneur.2023.1146027 |
| work_keys_str_mv | AT bergerjosephr commentaryprogressivemultifocalleukoencephalopathygeneticriskvariantsforpharmacovigilanceofimmunosuppressanttherapies AT hartunghanspeter commentaryprogressivemultifocalleukoencephalopathygeneticriskvariantsforpharmacovigilanceofimmunosuppressanttherapies |